AstraZeneca到2026年将在美国投资35亿美元,创造就业机会和扩大设施。 AstraZeneca will invest $3.5 billion in the U.S. by 2026, creating jobs and expanding facilities.

AstraZeneca计划到2026年向美国投资35亿美元,目的是扩大研究和制造业。 AstraZeneca plans to invest $3.5 billion in the U.S. by 2026, aiming to expand research and manufacturing. 这包括20亿美元的投资,以创造1 000多个高技能工作,建立设施,如马萨诸塞州一个新的研发中心,马里兰州的一个生物工程制造场。 This includes a $2 billion investment to create over 1,000 high-skilled jobs and establish facilities like a new R&D center in Massachusetts and a biologics manufacturing site in Maryland. 该投资反映了该公司在2030年之前提升美国最大的市场美国业务并达到800亿美元收入的战略。 The investment reflects the company's strategy to boost its U.S. operations, its largest market, and reach $80 billion in revenue by 2030.